Captrust Financial Advisors Grows Stake in The Cigna Group (NYSE:CI)

Captrust Financial Advisors lifted its stake in The Cigna Group (NYSE:CI) by 21.9% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 29,272 shares of the health services provider’s stock after acquiring an additional 5,262 shares during the quarter. Captrust Financial Advisors’ holdings in The Cigna Group were worth $10,141,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in The Cigna Group in the second quarter valued at approximately $66,000. Mather Group LLC. grew its holdings in The Cigna Group by 51.6% during the 2nd quarter. Mather Group LLC. now owns 917 shares of the health services provider’s stock valued at $333,000 after purchasing an additional 312 shares in the last quarter. Fulton Bank N.A. increased its stake in The Cigna Group by 2.7% during the 2nd quarter. Fulton Bank N.A. now owns 2,529 shares of the health services provider’s stock worth $836,000 after buying an additional 66 shares during the period. Kingswood Wealth Advisors LLC lifted its holdings in The Cigna Group by 81.4% in the 2nd quarter. Kingswood Wealth Advisors LLC now owns 3,680 shares of the health services provider’s stock worth $1,216,000 after buying an additional 1,651 shares in the last quarter. Finally, Park Avenue Securities LLC lifted its holdings in The Cigna Group by 8.2% in the 2nd quarter. Park Avenue Securities LLC now owns 12,521 shares of the health services provider’s stock worth $4,139,000 after buying an additional 952 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Price Performance

Shares of NYSE CI opened at $337.80 on Monday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The firm has a market capitalization of $93.96 billion, a PE ratio of 31.87, a P/E/G ratio of 1.02 and a beta of 0.51. The Cigna Group has a 1-year low of $253.95 and a 1-year high of $370.83. The business’s fifty day moving average price is $333.16 and its two-hundred day moving average price is $338.34.

The Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The business had revenue of $63.70 billion for the quarter, compared to analysts’ expectations of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company’s revenue for the quarter was up 29.8% compared to the same quarter last year. During the same quarter last year, the company earned $6.77 EPS. On average, research analysts expect that The Cigna Group will post 28.5 EPS for the current year.

The Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be issued a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a yield of 1.66%. The ex-dividend date is Wednesday, December 4th. The Cigna Group’s dividend payout ratio (DPR) is 52.83%.

Wall Street Analyst Weigh In

CI has been the topic of a number of analyst reports. JPMorgan Chase & Co. lifted their target price on The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. Stephens reaffirmed an “overweight” rating and issued a $410.00 target price on shares of The Cigna Group in a research report on Friday, November 1st. Jefferies Financial Group raised their price target on shares of The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a research report on Tuesday, September 17th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Finally, Royal Bank of Canada dropped their target price on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. One analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $394.64.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.